Depression Unraveled: Pathophysiology and Treatment Advances

Read full text
Authors: Anchel Sharma, Savita Verma, Dharminder Singh
Cited by: 0

Abstract

Depression is a complicated, long-lasting, and recurrent mental illness that has a major impact on emotional, cognitive, and physical functioning and has a huge negative impact on global health. The World Health Organization (WHO) estimates that over 280 million people worldwide suffer from depression, making it a substantial contributor to the global illness burden and a primary cause of disability. In addition to lowering quality of life, the disorder raises the risk of morbidity and mortality, especially from suicide and related illnesses including diabetes and cardiovascular disease. Depression has a complex etiology that includes genetic, neurological, psychological, and environmental factors. Additionally, there is growing evidence that oxidative stress and inflammatory cytokines have a role in the neuroprogression of depression. An integrative approach that combines medication, psychotherapy, and lifestyle changes is used to treat depression. The first-line pharmaceutical treatments are still antidepressants such selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and atypical antidepressants. Psychotherapeutic approaches including interpersonal therapy (IPT) and cognitive-behavioral therapy (CBT) have also demonstrated notable effectiveness in enhancing results. Electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and ketamine-based therapies are being used more frequently for treatment-resistant cases. The potential of probiotics, anti-inflammatory drugs, and nutraceuticals as supplemental therapies has also been emphasized by recent studies. An extensive grasp of depression, including its epidemiology, symptomatology, etiology, neurobiological underpinnings, diagnostic techniques, and treatment developments, is the goal of this review. It highlights the significance of early detection, individualized treatment, and holistic care in effectively managing depression by combining recent research.

Fields of Study & Subjects

Treatment of Major Depression Psychological Treatments and Disorders Tryptophan and brain disorders

Publication details

Journal / source
International Journal of Innovative Science and Research Technology (IJISRT)
Pages
2301–2301
Publication date
3 March 2026
Language
EN